semaglutide type 1 diabetes randomized trial 2024 Subcutaneously administered tirzepatide vs for adults with 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials | Diabetologia Reducing cardiometabolic risk with semaglutide

The most common side effects are mild nausea, occasional constipation, and reduced appetite, which is actually the intended effect

It is designed to be a long-acting peptide, usually researched in weekly administration protocols

While this medication can be taken without regard to meals, it is recommended that it be taken at the same time each day to improve compliance and reduce the potential for side effects

Liver fibrosis progression is governed by bidirectional crosstalk between T cells and hepatic stellate cells (HSCs)

Serious side effects such as pancreatitis and kidney issues require immediate medical attention

For indeterminate results, the enhanced liver fibrosis (ELF) test or liver elastography may be considered